ArticlePolicy, politics & nursing practice2021
Medicinal Cannabis: Policy, Patients, and Providers.
Article in Policy, politics & nursing practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 43 citations in OpenAlex.
- Exploring perceptions of cannabis use and employment implications among healthcare workers: a single-institution experience.Journal of cannabis research · 2026Article
- Isaac Campos. Home grown: Marijuana and the origins of Mexico's war on drugs.Addiction (Abingdon, England) · 2025Article
- Chronic Disease Symptoms Self-Managed by Cannabis During the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study.Cannabis and cannabinoid research · 2025Article
- Medicinal and combined medicinal/recreational cannabis use in California following the passage of Proposition 64.Journal of cannabis research · 2025Article
- The relationship between cannabis and cardiovascular disease: clearing the haze.Nature reviews. Cardiology · 2025Review
- Healthcare Professionals' Perceptions About Medical Cannabis in Greece: A Qualitative Study.Journal of market access & health policy · 2025Article
- Assessing the Market Readiness for Medical Cannabis in Greece: A Qualitative Study of Patient Perspectives.Medicines (Basel, Switzerland) · 2025Article
- Patient-provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study.The American journal on addictions · 2025Article
- Motherhood and medicinal cannabis.Drug and alcohol review · 2025Article
- Utilization of medicinal hemp: a qualitative analysis of clinicians' perspectives in Ghana.Journal of cannabis research · 2025Article
- Perceptions of Patient and Surgeon Marijuana Use: A Survey Study of Upper-Extremity Patients.Journal of hand surgery global online · 2025Article
- Effects of Cannabis Exposure on Adolescent Health and Development: A Narrative Review.Current drug research reviews · 2025Review
- Marketing Management and Policymaking for Medical Cannabis: Overcoming Barriers and Shaping Strategies.Cannabis (Albuquerque, N.M.) · 2025Article
- School Nurse Perspectives of Medical Cannabis Policy in K-12 Schools: An Exploratory Descriptive Study.The Journal of school nursing : the official publication of the National Association of School Nurses · 2024Article
- Patient-provider communication about the use of medical cannabis for cancer symptoms: a cross-sectional study.Journal of the National Cancer Institute. Monographs · 2024Article
- Potential role of cannabis in ameliorating observed racialized disparities in cancer pain management.Journal of the National Cancer Institute · 2024Article
- Understanding Pharmacy Students' Preparedness towards Counseling over Cannabis Use Disorder.Pharmacy (Basel, Switzerland) · 2024Article
- "We want what's best for patients." nurse leaders' attitudes about medical cannabis: A qualitative study.International journal of nursing studies advances · 2022Article
- Article
- Considerations for Cannabinoids in Perioperative Care by Anesthesiologists.Journal of clinical medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Medicinal cannabis is legal in some form in 47 states, 3 United States territories, and the District of Columbia. An estimated three million Americans use cannabis for relief of a variety of illnesses, and this figure is expected to grow based on policy changes. However, cannabis remains illegal at the federal level as a Schedule I drug under the 1970 Controlled Substances Act. Schedule I classification of cannabis has impeded the advancement of research, leaving providers with little evidence-based information to educate their patients. Furthermore, the disparities in individual state laws create significant social and health inequities in gaining access to medicinal cannabis. Conflicting state and federal policies regarding medicinal cannabis create logistical and ethical dilemmas, and all U.S. stakeholders-patients, providers, and health delivery systems-may be impacted by conflicting federal and state policies. This brief addresses the impact of conflicting cannabis policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.